ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Wuxi Biologics (Cayman) Inc
5.08
0.0000
成交量:
- -
成交额:
- -
市值:
209.98亿
市盈率:
47.21
高:
5.08
开:
5.08
低:
5.08
收:
5.08
52周最高:
5.61
52周最低:
2.26
股本:
41.38亿
流通股本:
37.33亿
量比:
0.00
换手率:
- -
股息:
- -
股息率:
- -
每股收益(TTM):
0.1075
每股收益(LYR):
0.1126
净资产收益率:
10.50%
总资产收益率:
5.89%
市净率:
3.23
市盈率(LYR):
45.06
数据加载中...
总览
公司
新闻资讯
公告
美国OTC市场药明生物盘中异动 急速跳水7.56%报4.16美元
市场透视
·
2025/11/19
医药板块回调与流感主题股逆势上涨分析
新浪财经
·
2025/11/10
美国OTC市场药明生物盘中异动 大幅跳水6.15%
市场透视
·
2025/10/22
创新药License-out火爆,价值重估进行时
同壁财经
·
2025/10/22
医疗器械行业周报:假期港股表现较好 继续看好Q3复苏趋势
中信建投证券
·
2025/10/08
CXO,一定要出去抢!
谈思生物
·
2025/09/27
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/WXIBF/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"WXIBF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WXIBF\",,,,,undefined,":{"symbol":"WXIBF","market":"US","secType":"STK","nameCN":"Wuxi Biologics (Cayman) Inc","latestPrice":5.075,"timestamp":1772744400000,"preClose":5.075,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":3732868601,"shares":4137541236,"eps":0.107499,"marketStatus":"盘前交易","change":0,"latestTime":"03-05 16:00:00 EST 延时","open":5.075,"high":5.075,"low":5.075,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.107499,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772807400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":5.075,"volumeRatio":0.0024553374184959034},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WXIBF\",,,,,undefined,":{"symbol":"WXIBF","floatShares":3732868601,"roa":"5.89%","roe":"10.50%","lyrEps":0.112637,"volumeRatio":0.0024553374184959034,"shares":4137541236,"dividePrice":0,"high":5.075,"amplitude":0,"preClose":5.075,"low":5.075,"week52Low":2.2566,"pbRate":"3.23","psRate":"7.24","week52High":5.606,"institutionHeld":0,"latestPrice":5.075,"eps":0.107499,"divideRate":0,"volume":0,"delay":15,"ttmEps":0.107499,"open":5.075,"prevYearClose":4.22,"prevWeekClose":5.075,"prevMonthClose":5.075,"prevQuarterClose":4.22,"fiveDayClose":4.89,"twentyDayClose":4.2785,"sixtyDayClose":4.04},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/WXIBF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-08-17","symbol":"WXIBF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1660708800000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2020-12-10","symbol":"WXIBF","type":"split","dateTimestamp":1607576400000,"forFactor":1,"toFactor":3,"ratio":0.333333},{"market":"US","date":"2020-11-16","symbol":"WXIBF","type":"split","dateTimestamp":1605502800000,"forFactor":1,"toFactor":3,"ratio":0.333333}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"WXIBF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"WXIBF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.6,"hold":0.2,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":25,"updateTime":1770699600000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"WXIBF\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2584972045","title":"美国OTC市场药明生物盘中异动 急速跳水7.56%报4.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584972045","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584972045?lang=zh_cn&edition=fundamental","pubTime":"2025-11-19 23:29","pubTimestamp":1763566140,"startTime":"0","endTime":"0","summary":"北京时间2025年11月19日23时29分,美国OTC市场药明生物股票出现异动,股价大幅下挫7.56%。截至发稿,该股报4.16美元/股,成交量840股,换手率0.00%,振幅0.00%。美国OTC市场药明生物股票所在的生物技术行业中,整体跌幅为0.25%。美国OTC市场药明生物公司简介:无锡药明康德集团是一家生物药物的合同开发和制造组织,简称“CDMO”。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119232901a704b14c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119232901a704b14c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","WXIBF"],"gpt_icon":0},{"id":"2582879993","title":"医药板块回调与流感主题股逆势上涨分析","url":"https://stock-news.laohu8.com/highlight/detail?id=2582879993","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582879993?lang=zh_cn&edition=fundamental","pubTime":"2025-11-10 20:00","pubTimestamp":1762776000,"startTime":"0","endTime":"0","summary":"在过去的两周中,医药板块面临一定的回调压力,主要指数普遍呈现震荡下跌的态势。尽管CXO板块的三季报业绩亮眼,但由于与创新药链条的密切关系,仍然出现了股价的下跌。这些与宏观经济状况相关的消极因素已经在医药板块的股价中得到了充分反映。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511102034379760415e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511102034379760415e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0456827905.SGD","03759","LU0516423174.USD","02269","LU1794554557.SGD","BK1515","LU0823426308.USD","LU0359202008.SGD","BK1521","SG9999002463.SGD","LU0708995583.HKD","LU1242518857.USD","BK1161","06160","LU0348825331.USD","LU3063872942.SGD","LU0140636845.USD","BK1589","LU0326950275.SGD","LU0052750758.USD","LU1720050803.USD","BK1574","LU0320764599.SGD","LU0039217434.USD","BK1610","LU0572944931.SGD","LU0051755006.USD","LU0359201612.USD","LU0181495838.USD","LU0979878070.USD","03347","LU0856984785.SGD","LU0417516738.SGD","06821","WXIBF","LU0348735423.USD","LU0516423091.SGD","09995","LU0516422366.SGD","LU0819121731.USD","BK1576","BK1141","LU0516422952.EUR","LU0307460666.USD","LU0823426480.USD","LU0516422440.USD","LU1242518931.SGD","LU1688375341.USD","LU1880383366.USD","06127","LU0588546209.SGD","IE00B0JY6N72.USD","09939","LU0417516902.SGD","SG9999002562.SGD","LU0327786744.USD","LU2039709279.SGD"],"gpt_icon":0},{"id":"2577434908","title":"美国OTC市场药明生物盘中异动 大幅跳水6.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577434908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577434908?lang=zh_cn&edition=fundamental","pubTime":"2025-10-22 22:52","pubTimestamp":1761144720,"startTime":"0","endTime":"0","summary":"北京时间2025年10月22日22时52分,美国OTC市场药明生物股票出现波动,股价急速下挫6.15%。美国OTC市场药明生物股票所在的生物技术行业中,整体跌幅为0.36%。美国OTC市场药明生物公司简介:无锡药明康德集团是一家生物药物的合同开发和制造组织,简称“CDMO”。它成立于 2010 年,隶属于药明康德,并于 2017 年在香港联交所上市。无锡药明康德报告称,2020年收入为56亿元人民币,三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022225201a46ec888&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022225201a46ec888&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WXIBF","BK4121"],"gpt_icon":0},{"id":"2577633992","title":"创新药License-out火爆,价值重估进行时","url":"https://stock-news.laohu8.com/highlight/detail?id=2577633992","media":"同壁财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577633992?lang=zh_cn&edition=fundamental","pubTime":"2025-10-22 11:15","pubTimestamp":1761102906,"startTime":"0","endTime":"0","summary":"医药魔方数据显示,2025年上半年License-out交易达72笔,已超2024年全年总量的一半;交易总金额较2024年全年高出16%,其中单笔超10亿美元的交易共16笔。License-out同期首付款总额首次超过一级市场融资总额,成为Biotech企业资金回流的关键路径,BD出海正逐步成为Biotech不可或缺的“输血”渠道。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022111705a46d83ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022111705a46d83ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2242644610.SGD","LU2045819591.USD","06978","BK1574","WXIBF","LU0708995583.HKD","LU1046422090.SGD","BK1583","LU2125910500.SGD","LU0052750758.USD","02359","BK1576","BK1141","LU0320764599.SGD","BK1161","02269"],"gpt_icon":0},{"id":"2573923583","title":"医疗器械行业周报:假期港股表现较好 继续看好Q3复苏趋势","url":"https://stock-news.laohu8.com/highlight/detail?id=2573923583","media":"中信建投证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573923583?lang=zh_cn&edition=fundamental","pubTime":"2025-10-08 00:00","pubTimestamp":1759852800,"startTime":"0","endTime":"0","summary":"其中微创医疗及部分子公司整体表现较好,预计与公告上海国资派驻董事参与董事会工作、治理改善和业绩修复预期相关;百心安和先健科技表现较好,预计与美国CMS有望将RDN纳入医保及TCT2025将公布铁基可降解支架最新数据等潜在事件催化有关。④关注中药、药店、流通、医疗服务及疫苗等行业经营触底回升节奏及长期转型升级方向。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510081826339723adab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510081826339723adab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4614","YANG","BK4121","WXIBF"],"gpt_icon":0},{"id":"2570852976","title":"CXO,一定要出去抢!","url":"https://stock-news.laohu8.com/highlight/detail?id=2570852976","media":"谈思生物","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570852976?lang=zh_cn&edition=fundamental","pubTime":"2025-09-27 11:00","pubTimestamp":1758942050,"startTime":"0","endTime":"0","summary":"既然药圈高处不胜寒,干脆换个赛道,蹲一蹲 CXO 的“洼地”。把视野放大,扫了眼国内 CXO 出海战绩,又对照了 Lonza 这类全球龙头,心里大概有了粗线条图景。如图,净利润同比飙升54.8%,增速相当惹眼。倘若把全球CXO的终局比作一条终点线,药明生物的赛程才跑到一半——Ⅲ期收入占比尚未过半,天花板还远在天边。微观来看,这是重写CXO世界版图;宏观而言,更是在撬动现有国际规则——只有把旧秩序撕开裂缝,中国产业链才算真正跨出国门。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250927111944a6a165e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250927111944a6a165e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WXIBF","LU0516423091.SGD","SG9999002463.SGD","LU0979878070.USD","LU0588546209.SGD","IE00B0JY6N72.USD","LU0348735423.USD","LU2039709279.SGD","SG9999002562.SGD","LU0819121731.USD","LU0052750758.USD","LU0516423174.USD","LU1794554557.SGD","LU0708995583.HKD","LU0516422952.EUR","LU0823426480.USD","LU1242518931.SGD","LU1688375341.USD","LU0456846285.SGD","LU0516422366.SGD","BK1576","LU0181495838.USD","LU0326950275.SGD","BK1589","LU0043850808.USD","LU0307460666.USD","LU0039217434.USD","BK1141","LU1720050803.USD","LU0823426308.USD","LU1242518857.USD","LU0051755006.USD","LU0320764599.SGD","LU0359202008.SGD","LU0417516738.SGD","LU0140636845.USD","LU0327786744.USD","LU0348825331.USD","02269","LU0572944931.SGD","BK1521","LU0856984785.SGD","LU0516422440.USD","LU0417516902.SGD","LU0456827905.SGD","LU0359201612.USD","LU1880383366.USD","BK1610"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}]}}